AMADIX is a company headquartered in Spain. Brouky records 1 investor associated with the company.
AMADIX develops blood-based diagnostic tests for early cancer detection. Its PreveCol test is aimed at detecting colorectal cancer and advanced adenomas.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.